Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T22:16:51.571Z.
Calculation as of: 2026-10-06T22:16:51.571Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6da64a8b1a2a274dcb8686c6d20e6c80d542b1d2a14b58c5ff35188fa74041c0
EARNINGS YIELD
N/A
Market Cap
$6.58M
Earnings Yield
N/A
TTM Avg
2.14%
3Y Avg
1.65%
5Y Avg
1.48%
Market Cap
$6.60M
Earnings Yield
N/A
TTM Avg
0.03%
3Y Avg
0.01%
5Y Avg
0.01%
Market Cap
$5.92M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.89M
Earnings Yield
N/A
TTM Avg
18.62%
3Y Avg
15.43%
5Y Avg
13.85%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Femasys Inc. (FEMY) | $6.28M | N/A | N/A | N/A | N/A |
| Scienture Holdings, Inc. (SCNX)vs › | $6.11M | N/A | N/A | N/A | N/A |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.58M | N/A | 2.14% | 1.65% | 1.48% |
| Aclarion, Inc. (ACON)vs › | $6.60M | N/A | N/A | N/A | N/A |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.60M | N/A | 0.03% | 0.01% | 0.01% |
| Biomerica, Inc. (BMRA)vs › | $6.61M | N/A | 0.84% | 1.16% | 1.47% |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $5.92M | N/A | N/A | N/A | N/A |
| Sonoma Pharmaceuticals, Inc. (SNOA)vs › | $5.89M | N/A | 18.62% | 15.43% | 13.85% |
| Lucyd, Inc (LUCY)vs › | $5.83M | N/A | N/A | N/A | N/A |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.82M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
